NuVasive

From Wikipedia, the free encyclopedia
NuVasive, Inc.
Type Public (NASDAQ: NUVA)
Industry Medical Technology
Founded 1997
Headquarters San Diego, California
Key people Alexis Lukianov (Chairman and CEO)
Products Medical Devices
Revenue $619 million (2012)
Website http://www.nuvasive.com/

NuVasive, Inc., based in San Diego, California, is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders.[1] NuVasive is a publicly traded company and is listed on the NASDAQ under the symbol NUVA.

NuVasive’s product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products.

MAS combines three categories of NuVasive’s current product offerings: NeuroVision, a proprietary software-driven nerve avoidance system; MaXcess, a unique split-blade design retraction system; and specialized implants. The MAS platform enables procedures such as XLIF, or eXtreme Lateral Interbody Fusion, a minimally disruptive spine surgery that accesses the spine through the patient’s side. This procedure is a more modern surgical option for treatment of scoliosis than the Harrington Rod, which is no longer used.

References

  1. ↑ http://finance.yahoo.com/q/pr?s=NUVA

External links

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.